RBOT insider Form 4: mandated sale of 653 shares for taxes

Rhea-AI Filing Summary

Vicarious Surgical Inc. director and executive reports small share sale. A reporting person who is a director, 10% owner, and Chief Technology Officer of Vicarious Surgical Inc. (RBOT) reported selling 653 shares of Class A common stock on 11/20/2025 at a weighted average price of $2.744 per share. After this transaction, the reporting person beneficially owned 33,862 shares directly.

The company explains that the sale was carried out under its equity incentive plan to cover tax withholding obligations arising from the vesting of restricted stock units granted on May 19, 2022, and that it was a mandated "sell to cover" transaction rather than a discretionary trade.

Insider Trade Summary

Net Seller: 653 shares ($1,792)

Net Sell 1 txn

Insider Khalifa Sammy

Role Chief Technology Officer

Sold 653 shs ($2K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	653	$2.744	$2K

Holdings After Transaction: Class A Common Stock — 33,862 shares (Direct)

Footnotes (1)

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $2.57 to $2.94 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khalifa Sammy

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/20/2025		S(1)		653	D	$2.744(2)	33,862	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

2. This figure is the weighted average sales price of multiple trades ranging from $2.57 to $2.94 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

	/s/ Sarah Romano, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vicarious Surgical (RBOT) report in this Form 4?

The filing reports that a director, 10% owner, and Chief Technology Officer of Vicarious Surgical Inc. (RBOT) sold 653 shares of Class A common stock on 11/20/2025.

At what price were the Vicarious Surgical (RBOT) shares sold?

The 653 shares were sold at a weighted average price of $2.744 per share, based on multiple trades ranging from $2.57 to $2.94 per share.

How many Vicarious Surgical (RBOT) shares does the insider own after the transaction?

Following the reported sale, the insider beneficially owns 33,862 shares of Vicarious Surgical Inc. Class A common stock directly.

Why did the Vicarious Surgical (RBOT) insider sell shares in this Form 4?

The sales were made to cover tax withholding obligations tied to the vesting of restricted stock units granted on May 19, 2022, under a mandated "sell to cover" arrangement in the company’s equity incentive plan.

Was the Vicarious Surgical (RBOT) insider trade discretionary?

The filing states that the sale does not represent a discretionary trade by the reporting person, but was mandated by the issuer’s election under its equity incentive plan.

Who signed the Vicarious Surgical (RBOT) Form 4?

The Form 4 was signed by /s/ Sarah Romano, Attorney-in-Fact, on 11/21/2025.